Cargando…

Case report: Isoflurane therapy in a case of status asthmaticus requiring extracorporeal membrane oxygenation

Volatile anesthetics have been described as a rescue therapy for patients with refractory status asthmaticus (SA), and the use of isoflurane for this indication has been reported since the 1980s. Much of the literature reports good outcomes when inhaled isoflurane is used as a rescue therapy for pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gill, Brendan, Bartock, Jason L., Damuth, Emily, Puri, Nitin, Green, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679515/
https://www.ncbi.nlm.nih.gov/pubmed/36425104
http://dx.doi.org/10.3389/fmed.2022.1051468
_version_ 1784834209589755904
author Gill, Brendan
Bartock, Jason L.
Damuth, Emily
Puri, Nitin
Green, Adam
author_facet Gill, Brendan
Bartock, Jason L.
Damuth, Emily
Puri, Nitin
Green, Adam
author_sort Gill, Brendan
collection PubMed
description Volatile anesthetics have been described as a rescue therapy for patients with refractory status asthmaticus (SA), and the use of isoflurane for this indication has been reported since the 1980s. Much of the literature reports good outcomes when inhaled isoflurane is used as a rescue therapy for patients for refractory SA. Venovenous (VV) extracorporeal membrane oxygenation (ECMO) is a mode of mechanical circulatory support that is usually employed as a potentially lifesaving intervention in patients who have high risk of mortality, primarily for underlying pulmonary pathology. VV ECMO is usually only considered in cases where patients gas exchange cannot be satisfactorily maintained by conventional therapy and mechanical ventilation strategies. We report the novel use of isoflurane delivered systemically as treatment for severe refractory SA in a patient on VV ECMO. A 51-year-old male with a history of asthma was transferred from another institution for management of severe SA. He was intubated at the referring hospital after failing non-invasive ventilation. Initial arterial blood gas (ABG) showed pH 7.21, partial pressure of carbon dioxide (PCO(2)) >95 mmHg, and partial pressure of oxygen (PaO(2)) 60 mmHg. VV ECMO was initiated on hospital day (HD) 1 due to refractory respiratory acidosis. After ECMO initiation, acid-base status improved, however, severe bronchospasm persisted and intrinsic positive end expiratory pressure (PEEP) was measured at 18 cm H(2)O. Systemic paralysis was employed, respiratory rate (RR) was reduced to 4 breaths per minute. This degree of bronchospasm did not allow for ECMO weaning. On HD 5, the patient received systemic isoflurane via the ECMO circuit for 20 h. The following morning, intrinsic PEEP was 4 cm H(2)O, and wheezing improved. He was decannulated from VV ECMO on HD 10 and extubated on HD 17. Inhaled isoflurane therapy in patients on VV ECMO for refractory SA has shown good results, but requires delivery of the medication via anesthesia ventilators. Our case highlights an effective alternative, systemic delivery of anesthetic via the ECMO circuit, as it is often difficult and dangerous to transport these patients to the operating room (OR) or have an intensive care unit (ICU) room adjusted to accommodate an anesthesia ventilator.
format Online
Article
Text
id pubmed-9679515
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96795152022-11-23 Case report: Isoflurane therapy in a case of status asthmaticus requiring extracorporeal membrane oxygenation Gill, Brendan Bartock, Jason L. Damuth, Emily Puri, Nitin Green, Adam Front Med (Lausanne) Medicine Volatile anesthetics have been described as a rescue therapy for patients with refractory status asthmaticus (SA), and the use of isoflurane for this indication has been reported since the 1980s. Much of the literature reports good outcomes when inhaled isoflurane is used as a rescue therapy for patients for refractory SA. Venovenous (VV) extracorporeal membrane oxygenation (ECMO) is a mode of mechanical circulatory support that is usually employed as a potentially lifesaving intervention in patients who have high risk of mortality, primarily for underlying pulmonary pathology. VV ECMO is usually only considered in cases where patients gas exchange cannot be satisfactorily maintained by conventional therapy and mechanical ventilation strategies. We report the novel use of isoflurane delivered systemically as treatment for severe refractory SA in a patient on VV ECMO. A 51-year-old male with a history of asthma was transferred from another institution for management of severe SA. He was intubated at the referring hospital after failing non-invasive ventilation. Initial arterial blood gas (ABG) showed pH 7.21, partial pressure of carbon dioxide (PCO(2)) >95 mmHg, and partial pressure of oxygen (PaO(2)) 60 mmHg. VV ECMO was initiated on hospital day (HD) 1 due to refractory respiratory acidosis. After ECMO initiation, acid-base status improved, however, severe bronchospasm persisted and intrinsic positive end expiratory pressure (PEEP) was measured at 18 cm H(2)O. Systemic paralysis was employed, respiratory rate (RR) was reduced to 4 breaths per minute. This degree of bronchospasm did not allow for ECMO weaning. On HD 5, the patient received systemic isoflurane via the ECMO circuit for 20 h. The following morning, intrinsic PEEP was 4 cm H(2)O, and wheezing improved. He was decannulated from VV ECMO on HD 10 and extubated on HD 17. Inhaled isoflurane therapy in patients on VV ECMO for refractory SA has shown good results, but requires delivery of the medication via anesthesia ventilators. Our case highlights an effective alternative, systemic delivery of anesthetic via the ECMO circuit, as it is often difficult and dangerous to transport these patients to the operating room (OR) or have an intensive care unit (ICU) room adjusted to accommodate an anesthesia ventilator. Frontiers Media S.A. 2022-11-08 /pmc/articles/PMC9679515/ /pubmed/36425104 http://dx.doi.org/10.3389/fmed.2022.1051468 Text en Copyright © 2022 Gill, Bartock, Damuth, Puri and Green. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Gill, Brendan
Bartock, Jason L.
Damuth, Emily
Puri, Nitin
Green, Adam
Case report: Isoflurane therapy in a case of status asthmaticus requiring extracorporeal membrane oxygenation
title Case report: Isoflurane therapy in a case of status asthmaticus requiring extracorporeal membrane oxygenation
title_full Case report: Isoflurane therapy in a case of status asthmaticus requiring extracorporeal membrane oxygenation
title_fullStr Case report: Isoflurane therapy in a case of status asthmaticus requiring extracorporeal membrane oxygenation
title_full_unstemmed Case report: Isoflurane therapy in a case of status asthmaticus requiring extracorporeal membrane oxygenation
title_short Case report: Isoflurane therapy in a case of status asthmaticus requiring extracorporeal membrane oxygenation
title_sort case report: isoflurane therapy in a case of status asthmaticus requiring extracorporeal membrane oxygenation
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679515/
https://www.ncbi.nlm.nih.gov/pubmed/36425104
http://dx.doi.org/10.3389/fmed.2022.1051468
work_keys_str_mv AT gillbrendan casereportisofluranetherapyinacaseofstatusasthmaticusrequiringextracorporealmembraneoxygenation
AT bartockjasonl casereportisofluranetherapyinacaseofstatusasthmaticusrequiringextracorporealmembraneoxygenation
AT damuthemily casereportisofluranetherapyinacaseofstatusasthmaticusrequiringextracorporealmembraneoxygenation
AT purinitin casereportisofluranetherapyinacaseofstatusasthmaticusrequiringextracorporealmembraneoxygenation
AT greenadam casereportisofluranetherapyinacaseofstatusasthmaticusrequiringextracorporealmembraneoxygenation